← FDA DRUG APPROVALS
FDA ANDA · ANDA216487
CIPROFLOXACIN AND DEXAMETHASONE
ciprofloxacin hydrochloride and dexamethasone
Sponsor: UPSHER SMITH LABS
APPLICATION
ANDA216487
TYPE
ANDA
ORIGINAL APPROVAL
2026-01-06
LATEST ACTION
2026-01-06
ROUTE
AURICULAR (OTIC), OTIC
DOSAGE FORM
SUSPENSION/DROPS
MARKETING STATUS
Prescription
Products
CIPROFLOXACIN AND DEXAMETHASONEPrescription
CIPROFLOXACIN 0.3%, DEXAMETHASONE 0.1% · SUSPENSION/DROPS · OTIC
Approval history
2026-01-06UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.